רספרים

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Dostupno od:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC koda:

J01EE01

Farmaceutski oblik:

תרחיף

Sastav:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Administracija rute:

פומי

Tip recepta:

מרשם נדרש

Proizveden od:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapijska grupa:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Područje terapije:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Terapijske indikacije:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Datum autorizacije:

2012-01-31